Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,206,561 papers from all fields of science
Search
Sign In
Create Free Account
CMFVP protocol
Known as:
Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine
, CVFMP protocol
, VPCMF
Expand
A combination of agents containing cyclophosphamide, fluorouracil, methotrexate, prednisone and vincristine.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (4)
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Methotrexate
cisplatin/cyclophosphamide/etoposide protocol
Fluorouracil
Prednisone
Vincristine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Update on Adjuvant Chemotherapy for Early Breast Cancer
A. Buzdar
,
G. Hortobagyi
2017
Corpus ID: 38425158
The Update on Adjuvant Chemotherapy for Early Breast Cancer, by Drs. McCarthy and Swain, provides an excellent and concise…
Expand
2000
2000
30 Jahre Internistische Onkologie in Deutschland
W. Queisser
Oncology Research and Treatment
2000
Corpus ID: 73244544
In dem Beitrag «50 Years of Cytostatic Chemotherapy», 1993 in dieser Zeitschrift publiziert [1], wurde die Entwicklung der…
Expand
1993
1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
S. Rivkin
,
S. Green
,
+6 authors
C. Osborne
Journal of Clinical Oncology
1993
Corpus ID: 24329140
PURPOSE To determine if prolonged adjuvant treatment (2 years v 1 year) with combination chemotherapy (cyclophosphamide…
Expand
1991
1991
Adjuvant combination chemotherapy cmfvp vs oophorectomy followed by cmfvp ocmfvp for premenopausal women with er positive operable breast cancer with positive axillary lymph nodes an intergroup study
S. Rivkin
,
S. Green
,
+5 authors
C. Osborne
1991
Corpus ID: 109550322
1988
1988
Chemotherapy of Mammary Cancer with Anthracyclins and Alkylators
K. Kolarić
1988
Corpus ID: 68208943
Over the past two and half decades the chemotherapy of disseminated breast cancer has involved three major stages. The first was…
Expand
1986
1986
Adjuvant therapy of breast cancer: Southwest Oncology Group studies.
C. Osborne
,
S. Rivkin
,
+4 authors
R. O'Bryan
NCI monographs : a publication of the National…
1986
Corpus ID: 24787363
The Southwest Oncology Group has conducted a series of randomized studies of adjuvant therapy in patients with primary breast…
Expand
1985
1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status
S. Rivkin
,
William A. Iii Knight
,
+5 authors
J. Costanzi
World Journal of Surgery
1985
Corpus ID: 7350950
This is a preliminary report of the Southwest Oncology Group in which therapy is randomized by estrogen receptor (ER) data…
Expand
1982
1982
A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study.
Raymond B. Weiss
,
D. Tormey
,
+5 authors
Oliver Glidewell
Recent results in cancer research. Fortschritte…
1982
Corpus ID: 2746936
The Cancer and Leukemia Group B (CALB) has conducted a randomized study of adjuvant chemotherapy in patients with breast cancer…
Expand
1982
1982
Prospects for Doxorubicin in Adjuvant Breast Cancer Trials
G. Bonadonna
,
C. Brambilla
,
A. Rossi
,
R. Buzzoni
,
A. Moliterni
,
P. Valagussa
1982
Corpus ID: 68966862
More than a decade ago, our medical oncology team initiated the first clinical studies on doxorubicin (1, 2) and, within the…
Expand
1981
1981
First, second and third line chemotherapy programs in metastatic breast carcinoma.
S. Rizel
,
A. Sulkes
,
E. Gez
,
G. Brufman
,
S. Biran
Israel journal of medical sciences
1981
Corpus ID: 45745966
The experience with three different chemotherapeutic regimes used as first, second and third line treatment in metastatic breast…
Expand